I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 8 studies | 17% ± 3% | |
| endothelial cell | 7 studies | 23% ± 8% | |
| natural killer cell | 6 studies | 19% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 5% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| epithelial cell | 4 studies | 29% ± 7% | |
| basal cell | 4 studies | 24% ± 7% | |
| glomerular endothelial cell | 3 studies | 32% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
| ciliated cell | 3 studies | 19% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 19% ± 2% | |
| gamma-delta T cell | 3 studies | 23% ± 10% |
